Metabolic
Survodutide
BI 456906
- Molecular format
- Modified peptide analog
Modified peptide analog
Research contextHuman studies exist
Read the linked studies for their methods and limitations.
A dual GLP-1 and glucagon receptor agonist with randomized human obesity research.
- Family
- Dual metabolic receptor agonist
- Research frame
- GLP-1 and glucagon receptors
- Molecular format
- Modified peptide analog
Read the evidence
The published phase 2 study is a dated evidence anchor. Review later trial records and tolerability alongside changes in body weight.
Resolve the identity
This receptor pair differs from tirzepatide’s GIP/GLP-1 profile and retatrutide’s triple profile.